Search
Search Results
##search.searchResults.foundPlural##
-
ACQUIRED REFRACTORY IRON DEFICIENCY
3544PDF: 1229HTML: 1180 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2518PDF: 1277HTML: 3613Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 427 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1954PDF: 803HTML: 555 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2061PDF: 108HTML: 29 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2833PDF: 1159HTML: 3305 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1535PDF: 813Suppl. Files: 341Html: 141 -
A MULTICENTER ICET-A STUDY ON AGE AT MENARCHE AND MENSTRUAL CYCLES IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA (TDT) WHO STARTED EARLY CHELATION THERAPY WITH DIFFERENT CHELATING AGENTS. Age at menarche and menstrual cycles in patients with transfusion-dependent thalassemia.
835PDF: 554HTML: 127 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2184PDF: 1585HTML: 647 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1800PDF: 880HTML: 1000 -
GLUCOSE METABOLISM AND INSULIN RESPONSE TO ORAL GLUCOSE TOLERANCE TEST (OGTT) IN PREPUBERTAL PATIENTS WITH TRANSFUSION DEPENDENT Β-THALASSEMIA (TDT): A LONG-TERM RETROSPECTIVE ANALYSIS Long-term retrospective analysis of glucose homeostasis in children with transfusion dependent β-thalassemia
1813PDF: 581HTML: 226 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2879PDF: 1858HTML: 3766Pellagatti Fig 1: 233Pellagatti Fig. 2: 230 -
-
Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients
1252PDF: 807HTML: 250 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1725PDF: 839HTML: 962cover letter: 288 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
1138PDF: 655HTML: 468 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2259PDF: 1345Html: 318 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3446PDF: 1392HTML: 2712 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4132PDF: 1177HTML: 2101Fig.1: 224Fig. 2: 120Table 1: 215Table2: 233Table 3: 212 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3566PDF: 1326HTML: 2026Fig.1: 226Fig. 2: 223 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2700PDF: 980HTML: 3724 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1118PDF: 1231HTML: 112 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2512PDF: 900HTML: 2552







